<SEC-DOCUMENT>0001214659-21-006499-index.html : 20210611
<SEC-HEADER>0001214659-21-006499.hdr.sgml : 20210611
<ACCEPTANCE-DATETIME>20210611174502
ACCESSION NUMBER:		0001214659-21-006499
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210610
FILED AS OF DATE:		20210611
DATE AS OF CHANGE:		20210611

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Humer Franz B
		CENTRAL INDEX KEY:			0001548072

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38693
		FILM NUMBER:		211012496

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET, 17TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Allogene Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001737287
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				823562771
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 457-2700

	MAIL ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>marketforms-53111.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: marketforms-53111.html

Document 1 - RAW XML: marketforms-53111.xml

</DOCUMENT>
</SEC-DOCUMENT>